Search results
View Tesla, Inc. TSLA stock quote prices, financial information, real-time forecasts, and company news from CNN.
- Tesla’s stock will rise 350% by 2025, analyst predicts - CNN
Ark Invest, run by the influential Cathie Wood, expects...
- GOOGL Stock Quote Price and Forecast | CNN
View Alphabet Inc. Class A GOOGL stock quote prices,...
- Tesla’s stock will rise 350% by 2025, analyst predicts - CNN
1 day ago · The company's revenue shot up a stunning 262% year over year to $26 billion while earnings jumped a massive 461% to $6.12 per share. Both numbers were better than what Wall Street was looking for ...
- Vaxart: 25,752% Implied Sales Growth by 2025
- CRISPR Technologies: 191,416% Implied Sales Growth by 2025
- Ocugen: 604,551% Implied Sales Growth by 2025
- Nikola: 2,970,426% Implied Sales Growth by 2025
A clinical-stage biotech stock angling for its first approved therapy is a perfect example of a business that could grow from a relatively small amount of non-recurring revenue to a considerably larger sum of recurring sales. Drug-developer Vaxart (VXRT-4.10%)is expected to increase its annual sales from the $4.05 million reported in 2020 to a cons...
Did I mention that clinical-stage biotech stocks are a great source of jaw-dropping growth over the next decade? CRISPR Therapeutics (CRSP-1.28%), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat diseases, is expected to see sales climb from $719,000 in 2020 to a consensus of $1.377 billion by 202...
Yet another clinical-stage biotech company expected to see sales go from virtually zero to a big number with a lot of zeroes is Ocugen (OCGN-3.65%). After the company reported $43,000 in sales last year, Wall Street's consensus has it generating $260 million in full-year sales by 2025. We're talking about a nearly 605,000% sales increase in five ye...
However, the crème de la crème of growth opportunities, at least pertaining to this list, is electric vehicle (EV) manufacturer Nikola (NKLA2.07%). The expectation is that we'll see Nikola's sales catapult from a reported $95,000 in 2020 to a consensus of $2.822 billion by 2025. This equates to almost a 3 million percent jump in annual revenue. The...
Mar 7, 2024 · Price Targets: Delving into movements, analysts provide estimates for the future value of NIO's stock. This analysis reveals shifts in analysts' expectations over time.
4 days ago · Prediction 2: Nvidia will still dominate the market for artificial intelligence (AI) chips a year from now. Prediction 3: Nvidia stock, which closed at $1,096.33 on Friday, could reach $1,700 a ...
